Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol NOTCH1 contributors: shn - updated : 06-10-2017
HGNC name notch 1
HGNC id 7881
ASSOCIATED DISORDERS
corresponding disease(s) TAN1 , FAVD1 , AOS5
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
constitutional     --over  
adult Down syndrome cortex
tumoral       gain of function
in T-cell lymphoblastic leukemias and lymphomas
constitutional     --over  
inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling
constitutional germinal mutation      
heart valve disease such as bicuspid aortic valve, hypoplastic left heart syndrome,aortic stenosis and other serious valvular anomalies with calcifications in many cases
tumoral       gain of function
activation of the Notch pathway, which is critical in glomerular patterning, contributes to the development of glomerular disease
constitutional       gain of function
causes severe osteosclerosis owing to increased proliferation of immature osteoblasts
constitutional     --low  
promotes osteoclastogenesis indirectly by enhancing the ability of osteoblast lineage cells to stimulate osteoclastogenesis
tumoral     --low  
in keratinocyte cancer cell lines and tumors
constitutional     --over  
in immune thrombocytopenic purpura
tumoral   deletion    
T cell-specific deletion of floxed NOTCH1 promoter/exon 1 sequences significantly accelerates leukemogenesis
Susceptibility to left ventricular outflow tract abnormalities
Variant & Polymorphism other mutations in left ventricular outflow tract malformations reduce ligand-induced signaling
Candidate gene
Marker
Therapy target
SystemTypeDisorderPubmed
cancerreproductiveprostate
down-regulation of Notch-1 by novel agents could become a newer approach for the prevention of tumor progression and/or treatment of prostate carcinoma
miscelleaneousurinary 
Notch activation in mature podocytes is a new mechanism in the pathogenesis of glomerular disease and thus could represent a new therapeutic target
osteoarticularboneostéoporosis
therapeutic inhibition of NOTCH signaling may adversely accelerate bone loss and osteoporosis (potential complication of therapeutic inhibition of NOTCH activity)
bloodcoagulation 
blockage of Notch1 pathway is likely a promising therapeutic concept in immune thrombocytopenic purpura
cancerhemopathy 
reversible activation of the Notch pathway may represent an attractive future therapy, targeting specifically the progression and relapse of granulocytic and monocytic neoplasms
ANIMAL & CELL MODELS
  • Notch1 mutant and Notch1/Notch4 double mutant mouse embryos displayed severe defects in angiogenic vascular remodeling
  • ablation of Notch1 in mouse skin resulted in epidermal and corneal hyperplasia followed by the development of skin tumors and facilitated chemical-induced skin carcinogenesis
  • doubly mouse embryos mutant for Notch1 and Notch2 exhibited multiple defects in left-right asymmetry
  • Notch1 -/- corneal progenitor mouse cells lost the ability to repair mechanically wounded corneal epithelium